Guo-ming Shen

Prof. Guo-ming Shen

orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2018 in Journal of Integrative Medicine
Verified
Journal Article
Closed access
RCRong-Lin Cai
Rong-Lin Cai
GSGuo-ming Shen
Guo-ming Shen
HWHao Wang
Hao Wang
YGYuan-Yuan Guan
Yuan-Yuan Guan

2 October 2023 in Gut Microbes
Verified
Journal Article
Open access
YYYi Yuan
Yi Yuan
XWXiyang Wang
Xiyang Wang
SHShun Huang
Shun Huang
HWHao Wang
Hao Wang
GSGuo-ming Shen
Guo-ming Shen
Irritable bowel syndrome is a common functional gastrointestinal disorder, and it has been shown that the etiology of irritable bowel syndrome is a multifactorial complex of neurological, inflammatory, and immunological changes. There is growing evidence of low-grade chronic inflammation in irritable bowel patients. The peripheral action response of their intestinal immune factors is integrated into the central nervous system, while the microbiota interacts with the brain-gut axis contributing to the development of low-grade chronic inflammation. The objective of this review is to present a discussion about the impact of immune-brain-gut axis-inflammation interactions on irritable bowel syndrome, its clinical relevance in the course of irritable bowel syndrome disease, and possible therapeutic modalities.

1 July 2021 in Annals of Translational Medicine
Verified
Journal Article
Open access
PDF file
HTHe-Yong Tang
He-Yong Tang
AJAi-Juan Jiang
Ai-Juan Jiang
XWXi-Yang Wang
Xi-Yang Wang
HWHao Wang
Hao Wang
YGYuan-Yuan Guan
Yuan-Yuan Guan
GSGuo-ming Shen
Guo-ming Shen
Objective: To improve the pathophysiological understanding of irritable bowel syndrome (IBS) by exploring the gut-brain axis. Background: Disorders of gut-brain interaction (DGBIs) are gastrointestinal (GI) disorders in which alterations in bowel functions occur. IBS, which is one of the most studied DGBIs, is linked with abdominal distress or pain without obvious structural or biochemical anomalies. Methods: The etiology of IBS has not been clearly described but is known to be multifactorial, involving GI motility changes, post-infectious reactivity, visceral hypersensitivity, gut-brain interactions, microbiota dysbiosis, small intestinal bacterial overgrowth, food sensitivity, carbohydrate malabsorption, and intestinal inflammation. Conclusions: One of the main features of IBS is the occurrence of structural and functional disruptions in the gut-brain axis, which alter reflective and perceptual nervous system reactions. Herein, we provide a brief summary of this topic. Furthermore, we discuss animal models, which are important in the study of IBS, especially as it is linked with stressors. These animal models cannot fully represent the human disease but serve as important tools for understanding this complicated disorder. In the future, technologies, such as organ-on-a-chip models and metabolomics, will provide novel information regarding the pathophysiology of IBS, which will play an important role in treatment development. Finally, we take a brief glance at how acupuncture treatments may hold potential for patients with IBS.

3 August 2021 in Journal of Gastroenterology and Hepatology
Verified
Journal Article
Open access
PDF file
XWXi‐Yang Wang
Xi‐Yang Wang
HWHao Wang
Hao Wang
YGYuan‐Yuan Guan
Yuan‐Yuan Guan
RCRong‐Lin Cai
Rong‐Lin Cai
GSGuo-ming Shen
Guo-ming Shen
Objectives: The therapeutic effect of acupuncture treatments (AT) on functional gastrointestinal disorders (FGIDs) is contentious. A meta‐analysis was conducted to assess the efficacy and safety of acupuncture for FGIDs.Methods: The Cochrane Library, EMBASE, PUBMED, Web of Science, Wanfang Database, China National Knowledge Infrastructure, and VIP Database were searched through December 31, 2019 with no language restrictions. Risk ratio (RR) with 95% confidence interval (CI) was calculated to determine the improvement in symptom severity after treatment.Results: A total of 61 randomized controlled trials (RCTs) on FGIDs were included. The pooled results illustrated the following: compared to pharmacotherapy (RR 1.13, 95% CI 1.09–1.17), placebo acupuncture (RR 1.69, 95% CI 1.37–2.08), no specific treatment (RR 1.86, 95% CI 1.31–2.62), and AT as an adjuvant intervention to other active treatments (RR 1.25, 95% CI 1.21–1.30), AT had more favorable improvements in symptom severity; sub‐group analysis results classified according to functional dyspepsia, irritable bowel syndrome, and functional constipation also supported this finding; and the incidence of adverse events was lower in AT than in other treatments (RR 0.75, 95% CI 0.56–0.99).Conclusions: This meta‐analysis found that AT was significantly associated with relief of FGIDs symptoms; however, the evidence level was moderate or low. Further data from rigorously designed and well powered RCTs are needed to verify the effectiveness and safety of AT as a FGIDs treatment.PROSPERO PROTOCOL NUMBER: CRD42020169508.

18 July 2019 in Endocrinology
Verified
Journal Article
Closed access
HTHe-Yong Tang
He-Yong Tang
AJAi-Juan Jiang
Ai-Juan Jiang
JMJun-Long Ma
Jun-Long Ma
FWFan-Jing Wang
Fan-Jing Wang
GSGuo-ming Shen
Guo-ming Shen
Worldwide, the most prevalent metabolic disorder is diabetes mellitus (DM), an important condition that has been widely studied. Diabetic peripheral neuropathy (DPN), a complication that can occur with DM, is associated with pain and can result in foot ulcers and even amputation. DPN treatments are limited and mainly focus on pain management. There is a clear need to develop treatments for DPN at all stages. To make this progress, it is necessary to understand the molecular signaling pathways related to DPN. For this review, we aimed to concentrate on the main signaling cascades that contribute to DPN. In addition, we provide information with regard to treatments that are being explored.

1 January 2020 in The Journal of Physiological Sciences
Verified
Journal Article
Open access
PDF file
HTHe-Yong Tang
He-Yong Tang
FWFan-Jing Wang
Fan-Jing Wang
JMJun-Long Ma
Jun-Long Ma
HWHao Wang
Hao Wang
GSGuo-ming Shen
Guo-ming Shen
AJAijuan Jiang
Aijuan Jiang
Diabetic peripheral neuropathy (DPN) is a chronic microvascular complication of diabetes. The purpose of this study is to find the underlying mechanism for the effects of acupuncture in DPN rats. Rats were rendered diabetic with a single injection of 35 mg/kg streptozotocin (STZ). These STZ-diabetic rats were treated with acupuncture for 20 min once daily. The therapeutic efficacy of acupuncture was assessed using mechanical withdrawal threshold (MWT) and thermal withdrawal latency (TWL) evaluations. After 14 days treatment, acupuncture markedly reduced the pathological injury in STZ-diabetic rats. Moreover, it significantly down-regulated P2X4 and OX42 expression along with the reduced levels of inflammatory factors (CXCR3, TNF-α, IL-1β, IL-6), GSP and lipid metabolisms in the spinal cord of the DPN rats. Acupuncture could relieve DPN in rats by regulating P2X4 expression and inflammation in spinal microglia.